Biologics Manufacturing Innovation For Medicine Supply Security

Scientists Mixing Solution In Lab GettyImages-1443286944

Global patient demand for biological medicines continues to grow, driven by an increasing burden of cancers, infectious disease, and immunological and neurological disorders. The World Economic Forum reports medicine supply challenges are being faced around the world, leading to medicine shortages. Companies manufacturing biologics must have resilient supply chains that can be adapted to circumstances, such as meeting the needs of niche markets, addressing the threat of pandemics, and controlling the costs of new medicines.

FUJIFILM Diosynth Biotechnologies is fostering trusting partnerships with clients by executing its strategy of building a global network of modular-designed large-scale and single-use facilities through an aligned production platform. This will allow customers to rapidly ramp up production and transfer processes at unprecedented speed. To support clients further, we have developed an innovative single-use continuous biomanufacturing platform, providing even more agility and the potential to improve product quality while reducing medicine production costs.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

FUJIFILM Diosynth Biotechnologies